TECENTRIQ
NDC 50242-918, atezolizumab, injection, solution, from Genentech, Inc..
- Product NDC
- 50242-918
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761034
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-918 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATEZOLIZUMAB840 mg/14mL
Pharmacologic classes
Antibodies [CS]; Antibodies, Monoclonal [CS]; Antibodies, Monoclonal, Humanized [CS]; Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-918-01 | 50242091801 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-918-01) / 14 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6fa682c9-a312-4932-9831-f286908660eeMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-918
Use it
Look up 50242-918 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-918 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-918. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.